Stryker Corporation SYK
Regular-session close
After hours · Nov 17, 7:59 PM ET
- YTD
- -9.65%
- 1 year
- -11.83%
- Market cap
- 120.88B
- Revenue (ttm)
- 26.30B
- Profit margin
- 13.78%
- EPS (ttm)
- 9.39
- Shares out
- 380.69M
- P/E ratio
- 33.82
- Forward P/E
- 19.50
- Dividend
- 3.52 (1.13%)
- Ex-dividend date
- Sep 30, 2026
- YTD return
- -9.65%
- 1-year return
- -11.83%
- Volume
- 4.57M
- Avg volume
- 2.90M
- Open
- 309.12
- Previous close
- 310.72
- Day's range
- 308.00 – 319.33
- 52-week range
- 267.00 – 389.33
- Beta
- 0.77
- Analysts
- Buy
- Price target
- 339.37 (+6.9%)
- Earnings date
- Feb 4, 2027
- 50-day average
- 292.40
5D -1.44 (-0.45%)
Key statistics
- 200-day average
- 321.64
- Enterprise value
- 130.45B
- PEG ratio
- 1.50
- Price / sales
- 4.60
- Price / book
- 5.15
- Payout ratio
- 37.49%
- Revenue growth
- 7.60%
- Free cash flow
- 3.70B
- Total cash
- 3.27B
- Total debt
- 15.43B
- Return on equity
- 16.02%
- Short % of float
- 1.83%
Fundamental scorecard
20 of 25 checks passed on SYK’s reported financials
20of 25 checks passed
- Value 3 of 5
- Growth 5 of 5
- Profitability 5 of 5
- Financial health 3 of 5
- Dividend 4 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: buy
- Target (low)
- 275.00
- Target (mean)
- 339.37
- Target (high)
- 410.00
- Strong buy8
- Buy14
- Hold8
- Sell0
- Strong sell0
Next earnings
Feb 4, 2027
Expected Feb 4, 2027. Consensus EPS estimate 5.02.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2027 | Dec 30, 2026 | 5.03 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 3.55 | 3.52 | -0.03 | -0.85% |
| Jul 30, 2026 | Jun 30, 2026 | 3.49 | 3.69 | +0.20 | +5.73% |
| Apr 30, 2026 | Mar 31, 2026 | 2.98 | 2.60 | -0.38 | -12.75% |
| Jan 29, 2026 | Dec 31, 2025 | 4.40 | 4.47 | +0.07 | +1.59% |
| Oct 30, 2025 | Sep 30, 2025 | 3.13 | 3.19 | +0.06 | +1.92% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 9, 2026 | Piper Sandler | main | Overweight | Overweight |
| Nov 2, 2026 | Truist Securities | reit | Hold | Hold |
| Nov 2, 2026 | Stifel | main | Buy | Buy |
| Oct 30, 2026 | JP Morgan | main | Overweight | Overweight |
| Oct 30, 2026 | Citigroup | main | Buy | Buy |
| Oct 30, 2026 | TD Cowen | main | Hold | Hold |
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- stryker.com
News
Block To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Monday Piper Sandler Maintains Overweight on Stryker, Raises Price Target to $350
Here's How Much $1000 Invested In Stryker 15 Years Ago Would Be Worth Today Truist Securities Reiterates Hold on Stryker, Lowers Price Target to $305
JP Morgan Maintains Overweight on Stryker, Lowers Price Target to $340
Citigroup Maintains Buy on Stryker, Lowers Price Target to $315
TD Cowen Maintains Hold on Stryker, Lowers Price Target to $290
RBC Capital Maintains Outperform on Stryker, Lowers Price Target to $375
Barclays Maintains Overweight on Stryker, Lowers Price Target to $365
Canaccord Genuity Downgrades Stryker to Hold, Lowers Price Target to $300
Your note
Sign in to keep a note on SYK — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BECKER YIN C | Officer | Conversion of Exercise of derivative security | Mar 20, 2025 | 36,052 |
| CROTTY DYLAN BRAM | Officer | Sale | Aug 20, 2026 | 0 |
| FINK MARY KATHRYN | Officer | Sale | May 10, 2026 | 0 |
| GOLSTON ALLAN C | Director | Conversion of Exercise of derivative security | Feb 17, 2025 | 14,895 |
| LOBO KEVIN A | Chief Executive Officer | Conversion of Exercise of derivative security | Mar 19, 2026 | 222,952 |
| MENON VIJU S | Officer | Conversion of Exercise of derivative security | Mar 19, 2026 | 17,580 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 7.12% | 27,118,799 | 8.61B | Sep 29, 2026 |
| Vanguard Capital Management LLC | 5.97% | 22,720,283 | 7.22B | Sep 29, 2026 |
| State Street Corporation | 4.15% | 15,799,557 | 5.02B | Sep 29, 2026 |
| Greenleaf Trust | 3.98% | 15,155,933 | 4.81B | Sep 29, 2026 |
| JPMORGAN CHASE & CO | 3.23% | 12,281,126 | 3.90B | Sep 29, 2026 |
| Wellington Management Group, LLP | 2.63% | 10,022,352 | 3.18B | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.88% | 10,952,979 | 3.48B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.35% | 8,941,926 | 2.84B | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.22% | 4,650,741 | 1.48B | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.19% | 4,536,259 | 1.44B | Sep 29, 2026 |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 1.13% | 4,318,841 | 1.37B | Sep 29, 2026 |
| SELECT SECTOR SPDR TRT-State Street Health Care Select Sector SPDR ETF | 0.65% | 2,469,410 | 784.28M | Sep 29, 2026 |
